Tennessee Senate Bill SB2081

Tennessee 2025-2026 Regular Session

• Introduced: 1/22/26

Caption

AN ACT to amend Tennessee Code Annotated, Title 8; Title 56; Title 63; Title 68 and Title 71, relative to step therapy.

Impact

The bill modifies existing regulations governing how health benefit plans in Tennessee handle coverage for cancer treatment. By eliminating specific references to certain stages of cancer, the bill seeks to streamline the process through which patients can access necessary medications. It intends to improve healthcare accessibility for individuals diagnosed with cancer, particularly ensuring that insurers cannot impose additional hurdles that could delay treatment. This legislative change reflects a growing emphasis on patient-centered care within the healthcare system.

Summary

Senate Bill 2081 seeks to amend several titles of the Tennessee Code Annotated, specifically focusing on step therapy protocols in healthcare plans. Step therapy is a practice used by health insurers where patients are required to try and fail on certain medications before the insurer will cover the prescribed treatment. SB2081 aims to remove specific references to stage 4 advanced metastatic cancers and instead broadly allows coverage for cancer treatments without requiring prior step therapy. This change aims to improve patient access to timely and appropriate cancer care.

Contention

One notable point of contention surrounding SB2081 could involve healthcare providers and insurance companies debate over the cost implications of removing step therapy protocols. Insurance companies may argue that step therapy is a cost-saving mechanism aimed at encouraging the use of less expensive treatments before moving to pricier options. On the other hand, advocates for patient rights and healthcare access may push back against such practices, indicating that they can lead to delays in receiving effective treatment forms, thereby adversely impacting patient health outcomes.